Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Assess the Efficacy and Safety of the AV5080 Drug in Patients With Influenza

NCT05095545 is registered in ClinicalTrials.gov with Viriom as lead sponsor.

NCT NCT05095545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05095545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Assess the Efficacy and Safety of the AV5080 Drug in Patients With Influenza
Lead sponsor
Viriom
Phase
Phase 2
Overall status
Completed
Start date
November 13, 2017
Completion date
August 30, 2019
Enrollment
135 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

influenza